AUH expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.138800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.357400E-01
Normal-vs-Stage2
7.255200E-01
Normal-vs-Stage3
3.532300E-02
Normal-vs-Stage4
9.889800E-01
Stage1-vs-Stage2
5.293000E-01
Stage1-vs-Stage3
5.971700E-02
Stage1-vs-Stage4
9.232200E-01
Stage2-vs-Stage3
4.694400E-02
Stage2-vs-Stage4
7.027400E-01
Stage3-vs-Stage4
8.020200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.143400E-01
Normal-vs-AfricanAmerican
7.260200E-01
Normal-vs-Asian
6.314200E-01
Caucasian-vs-AfricanAmerican
4.417400E-01
Caucasian-vs-Asian
5.806200E-01
AfricanAmerican-vs-Asian
3.149600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.262600E-01
Normal-vs-Female
9.093000E-01
Male-vs-Female
4.496000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.188400E-01
Normal-vs-Age(41-60Yrs)
8.504600E-01
Normal-vs-Age(61-80Yrs)
6.761400E-01
Normal-vs-Age(81-100Yrs)
4.943600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.763200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.778600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.021600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.347900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.525240E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.252400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.398200E-01
Normal-vs-Daily Drinker
9.576600E-01
Normal-vs-Weekly Drinker
1.520810E-01
Normal-vs-Occasional Drinker
8.060400E-01
Normal-vs-Social Drinker
9.827000E-01
Non Drinker-vs-Daily Drinker
2.191800E-01
Non Drinker-vs-Weekly Drinker
2.842800E-01
Non Drinker-vs-Occasional Drinker
1.706000E-01
Non Drinker-vs-Social Drinker
2.725200E-01
Daily Drinker-vs-Weekly Drinker
4.324100E-02
Daily Drinker-vs-Occasional Drinker
6.717600E-01
Daily Drinker-vs-Social Drinker
9.516800E-01
Weekly Drinker-vs-Occasional Drinker
4.308000E-02
Weekly Drinker-vs-Social Drinker
7.367700E-02
Occasional Drinker-vs-Social Drinker
6.607200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.031000E-01
Normal-vs-Grade 2
1.118820E-01
Normal-vs-Grade 3
4.218100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.028000E-01
Grade 1-vs-Grade 3
2.515000E-01
Grade 1-vs-Grade 4
2.031000E-01
Grade 2-vs-Grade 3
8.178800E-01
Grade 2-vs-Grade 4
1.118820E-01
Grade 3-vs-Grade 4
4.218100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.779600E-01
Normal-vs-NonDiabetic
9.098200E-01
Diabetic-vs-NonDiabetic
1.282980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.831600E-01
Normal-vs-NoPancreatitis
8.167000E-01
Pancreatitis-vs-NoPancreatitis
7.426800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.751000E-01
Normal-vs-N1
7.282400E-01
N0-vs-N1
4.389800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.579200E-01
Normal-vs-TP53-NonMutant
8.127800E-01
TP53-Mutant-vs-TP53-NonMutant
8.001900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
